Virus-like particles as a vaccine delivery system: myths and facts.
about
Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responsesRecent vaccine technology in industrial animalsPlant-produced viral bovine vaccines: what happened during the last 10 years?Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virusChimeric infectious bursal disease virus-like particles as potent vaccines for eradication of established HPV-16 E7-dependent tumorsCrystal ball - 2011Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving targetEgg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses.Swine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice.Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccinesChimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.Virus-like particles as universal influenza vaccinesAntigen vehiculization particles based on the Z protein of Junin virus.A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challengeTLR7 and 9 agonists are highly effective mucosal adjuvants for norovirus virus-like particle vaccinesImprovement of different vaccine delivery systems for cancer therapy.Structural plasticity of a transmembrane peptide allows self-assembly into biologically active nanoparticlesProteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity.Mannosylation of virus-like particles enhances internalization by antigen presenting cellsEnhanced effect of DNA immunization plus in vivo electroporation with a combination of hepatitis B virus core-PreS1 and S-PreS1 plasmidsHendra and nipah infection: pathology, models and potential therapies.The economic value of a visceral leishmaniasis vaccine in Bihar state, India.Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses.Whole recombinant Pichia pastoris expressing HPV16 L1 antigen is superior in inducing protection against tumor growth as compared to killed transgenic LeishmaniaHSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in miceStructural analysis and insertion study reveal the ideal sites for surface displaying foreign peptides on a betanodavirus-like particle.Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles.Prospects for improved bluetongue vaccines.Materials engineering for immunomodulation.Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.Virus engineering: functionalization and stabilization.Insect cell technology is a versatile and robust vaccine manufacturing platform.Light it up: highly efficient multigene delivery in mammalian cells.Vaccine process technology.Delivery of antigens used for vaccination: recent advances and challenges.SV40 virus-like particles as an effective delivery system and its application to a vaccine carrier.Insect cells as a production platform of complex virus-like particles.Suitability and perspectives on using recombinant insect cells for the production of virus-like particles.Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology.
P2860
Q24624348-7CC6ADC2-BE02-4A35-BD19-A491F007A708Q26766625-40C06128-1B85-4F80-B622-F02BB3D10D74Q26801335-35BAE21D-FD0F-4CE4-89D0-0D19D8774E21Q28473294-00589EB3-9C2A-401C-9CAC-13129850DBB7Q28484683-D02CEE94-BE0E-438F-B79F-B35EC2B17FDCQ28661746-CEBA1443-6573-460D-97EC-BA1C5987D75BQ30227194-EB5F5EF2-F23B-4CEB-8A3C-02ACEFD32E27Q30382097-293B0D6F-A73D-45E5-9392-F6DFA670ADA7Q30383973-DFE3AD40-1544-4DCE-B47A-CF43AA24D86BQ30387030-0CCABFB3-33D1-41E3-8D71-29F8682C0EF3Q30404941-CA916B1C-93CF-4C96-B4BE-7B9813989D5EQ30421558-CCA91631-6634-43A8-865B-AB7683882508Q31106232-20D12415-761C-4A39-AD49-1215BC883B92Q33621078-A9BAC9D9-7052-4EF4-B28F-A59B00E09B7BQ34290717-CF43F211-1253-43E1-890B-B6D58A35DEC4Q34506877-1E21AFB6-DF3A-4A14-9084-043EA892D57BQ35049224-BFAA526E-C9F3-49CF-9BEA-75050E61FDFCQ35151690-FEEE0550-6F22-4E74-A8CB-C74D6D329966Q35224806-3C629083-22F7-44F0-8EB0-DCBB80DA435FQ35530249-6C7D7A3E-CB1F-4CEA-B79C-C5649FE56E19Q35658146-A67A0D8D-91E2-49E9-98D3-F0F363BD49B3Q35771782-B916B089-78A6-4A86-B880-8A61CEFA769DQ35841913-55683C75-D3FB-4F42-968D-793912EC81A4Q35886738-D21D6B14-B1AE-4D83-B51A-376FA7215A28Q36220629-E3C12F35-9C37-4779-A1ED-635D5447BA95Q36454704-CACDB0C0-47CD-4C57-AC3E-07ED839EC232Q36685400-CA7ADC55-2F76-4074-977E-E005E59E8E51Q37247965-11E77564-7EB8-42DD-B79F-31AA62A1E45AQ37369882-E55AEFE7-B3F3-43E2-A345-5A29111452E0Q37639157-D5246BE2-EA2E-4A73-A260-118C2DC02F57Q37792984-AEEE46CB-E668-4CFC-B620-CDFDEC8B32E9Q37798083-987736BD-CBA2-440B-A386-A890CD3F5513Q37909427-F36093CE-B0B8-4737-9906-391962D13357Q37946209-BA737DE5-0E33-4444-80CB-CC2518AF1DF6Q37992586-5F74E91C-9DF3-4319-8F46-88B665510A7DQ38028969-5511CAE2-D858-45B2-9B5F-E913FF2738BDQ38081973-F0F54E8E-D8A3-4440-92BE-AE261C7DA2EEQ38081976-F2E9E756-C621-43A1-9102-F56AE7DC2767Q38177170-FE29479B-1592-479B-A0AF-0022A3E1EC5AQ38285751-E536C9FD-D447-402D-8F4E-B92767A3BE71
P2860
Virus-like particles as a vaccine delivery system: myths and facts.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Virus-like particles as a vaccine delivery system: myths and facts.
@en
Virus-like particles as a vaccine delivery system: myths and facts.
@nl
type
label
Virus-like particles as a vaccine delivery system: myths and facts.
@en
Virus-like particles as a vaccine delivery system: myths and facts.
@nl
prefLabel
Virus-like particles as a vaccine delivery system: myths and facts.
@en
Virus-like particles as a vaccine delivery system: myths and facts.
@nl
P356
P1433
P1476
Virus-like particles as a vaccine delivery system: myths and facts
@en
P2093
P356
10.4161/HV.4.1.5559
P50
P577
2008-01-11T00:00:00Z